Ibandronate
Spezifikationen
114084-78-5CAS-Nummer
688-095-0EG-Nummer
[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acidIUPAC-Name
C9H23NO7P2Chemische Formel
319.23 g/molMolekulargewicht
Ibandronic Acid; Ibandronate; 114084-78-5; Bondenza; Iasibon; {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonic acid; Ibandronic Acid Teva; Ibandronic Acid Accord; Ibandronic Acid Sandoz; Acido ibandronico; acide ibandronique; [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid; UMD7G2653W; NSC-722623; DTXSID5048340; RPR-102289A; Quodixor; (1-hydroxy-3-(methyl(pentyl)amino)-1-phosphonopropyl)phosphonic acid; acidum ibandronicum; RefChem:56785; BM 210955; 1-hydroxy-3-(methylpentylamino)propylidenebisphosphonate; DTXCID6028315; (1-hydroxy-3-(methylpentylamino)propylidene)bisphosphonate; M05BA06; RPR102289A; BM210955; BM21.0955; Bondronat; Bonviva; Phosphonic acid, P,P'-[1-hydroxy-3-(methylpentylamino)propylidene]bis-; C9H23NO7P2; Ibandronic acid (INN); MFCD00868772; CHEMBL997; (1-Hydroxy-3-(methylpentylamino)propylidene)diphosphonic acid; Phosphonic acid, [1-hydroxy-3-(methylpentylamino)propylidene]bis-; Acid ibandronico; [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphonic acid; BFQ; IBANDRONIC ACID [INN]; Ibandronic acid [INN:BAN]; Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-; (1-Hydroxy-3-(methyl(pentyl)amino)propane-1,1-diyl)diphosphonic acid; Bisphosphonate 2; {1-hydroxy-3-[methyl(pentyl)amino]propane-1,1-diyl}bis(phosphonic acid); SR-05000001496; UNII-UMD7G2653W; R484; [1-HYDROXY-3-(METHYL-PENTYL-AMINO)-1-PHOSPHONO-PROPYL]-PHOSPHONIC ACID; IBANDRONATE [VANDF]; SCHEMBL9183; IBANDRONIC ACID [MI]; GTPL3059; JMC515594 Compound 53; orb1226925; orb1308067; IBANDRONIC ACID [MART.]; BDBM12577; HY-B0515A; IBANDRONIC ACID [WHO-DD]; MPBVHIBUJCELCL-UHFFFAOYSA-N; HMS2090A13; IBANDRONIC ACID [EMA EPAR]; AC-521; EBC-26783; AKOS015855723; DB00710; NSC 722623; AS-12948; NS00014340; D08056; EN300-304883; H37001; AB01275485-01; Q166825; SR-05000001496-1; SR-05000001496-2; BRD-K08681769-323-01-1; BRD-K08681769-323-03-7; BRD-K08681769-323-04-5; BRD-K08681769-323-05-2Synonyme
Produkte, die Ibandronate enthalten
BONVIVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULABONVIVA 3 mg SOLUCION INYECTABLE EN JERINGA PRECARGADABONVIVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULABONVIVA 150 mg, COMPRIMIDOS RECUBIERTOS CON PELICULABONDRONAT 6 mg CONCENTRADO PARA SOLUCION PARA PERFUSIONBONDRONAT 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULABONDRONAT 2 mg CONCENTRADO PARA SOLUCION PARA PERFUSIONACIDO IBANDRONICO VIR 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGACIDO IBANDRONICO TEVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGACIDO IBANDRONICO TEVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGACIDO IBANDRONICO TARBIS 150 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGACIDO IBANDRONICO RATIOPHARM 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Seite 1 von 4
Unternehmen, die Ibandronate verkaufen
SI
Sinoway Industrial Co.Ltd.ChinaTP
Teva Pharma S.L.U.SpainSeite 1 von 3